Topiramate
Product Images NDC 53808-1132

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 53808-1132). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Doh Central Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image For 25mg (Topiramate 25mg)

This is a label for a medication called Topiramate, which comes in 25mg tablets. The label also indicates that the prescription is for 30 tablets and that it was filled by 2ZY Generics. The medication should be used before the expiration date of 06-13-2018. The label includes information on the package being filled by the DOH Central Pharmacy in Tallahassee. There is also a code, UPGH 368382136057, which is likely a unique identifier for the medication.*

FDA Label Image

Structured Product Formula For Topiramate (Af70d392 31a6 40bb 8f0a Ab51a70067fb 01)

FDA Label Image

Structured Product Formula For Topiramate (Af70d392 31a6 40bb 8f0a Ab51a70067fb 02)

FDA Label Image

Topiramate Tablets Usp (Af70d392 31a6 40bb 8f0a Ab51a70067fb 03)

This text presents data on the change in the average monthly migraine period rate from baseline to the double-blind phase for different doses of topiramate and a placebo. The study was conducted in two parts or studies (I and II). The table shows the number of participants (N) for each treatment group. The results indicate that all doses of topiramate were more effective in reducing the migraine period rate compared to the placebo. The asterisks denote significant differences between groups.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.